Crescent Sterling’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.6M Buy
22,059
+139
+0.6% +$32.4K 5.01% 2
2026
Q1
$5.36M Buy
21,920
+10
+0% +$2.33K 5.18% 2
2025
Q4
$4.53M Sell
21,910
-73
-0.3% -$14.4K 4.65% 5
2025
Q3
$4.08M Sell
21,983
-231
-1% -$39.6K 4.29% 5
2025
Q2
$3.39M Sell
22,214
-1,421
-6% -$218K 3.8% 5
2025
Q1
$3.92M Buy
23,635
+396
+2% +$62K 4.02% 6
2024
Q4
$3.36M Buy
23,239
+72
+0.3% +$11.2K 3.45% 8
2024
Q3
$3.75M Buy
23,167
+22
+0.1% +$3.5K 3.58% 8
2024
Q2
$3.38M Sell
23,145
-137
-0.6% -$20.4K 3.24% 8
2024
Q1
$3.68M Sell
23,282
-505
-2% -$80.4K 3.36% 8
2023
Q4
$3.73M Sell
23,787
-815
-3% -$125K 3.72% 5
2023
Q3
$3.83M Sell
24,602
-5,960
-20% -$983K 4.05% 5
2023
Q2
$5.06M Buy
30,562
+687
+2% +$111K 4.8% 3
2023
Q1
$4.63M Buy
29,875
+2,928
+11% +$473K 4.5% 3
2022
Q4
$4.76M Buy
+26,947
New +$4.65M 5.11% 2

Other funds holding JNJ

Crescent Sterling's JNJ Position: Q2 2026 in Review

Crescent Sterling increased its Johnson & Johnson (JNJ) stake by 0.63% in Q2 2026, buying an estimated $32.4K and bringing the position to 22,059 shares worth $5.6M. The position accounts for 5.01% of the portfolio, ranked #2.

Crescent Sterling first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. 1,357 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Crescent Sterling held 22,059 shares of Johnson & Johnson worth $5.6M as of Q2 2026.
  • Crescent Sterling bought 139 Johnson & Johnson shares in Q2 2026, an estimated $32.4K.
  • Johnson & Johnson made up 5.01% of Crescent Sterling's portfolio in Q2 2026, its #2 holding.
  • Crescent Sterling first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
  • 1,357 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Crescent Sterling's 13F filing for Q2 2026, filed 7 Jul 2026.